Hau Van Phan

Array ( [id] => 3730290 [patent_doc_number] => 05698195 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies' [patent_app_type] => 1 [patent_app_number] => 8/324799 [patent_app_country] => US [patent_app_date] => 1994-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 33 [patent_no_of_words] => 52631 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698195.pdf [firstpage_image] =>[orig_patent_app_number] => 324799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855133 [patent_doc_number] => 05792458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Mutant diphtheria toxin conjugates' [patent_app_type] => 1 [patent_app_number] => 8/323591 [patent_app_country] => US [patent_app_date] => 1994-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 11926 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792458.pdf [firstpage_image] =>[orig_patent_app_number] => 323591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870204 [patent_doc_number] => 05747033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method of enhancing the biological activity of Eph family ligands' [patent_app_type] => 1 [patent_app_number] => 8/299567 [patent_app_country] => US [patent_app_date] => 1994-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 10576 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747033.pdf [firstpage_image] =>[orig_patent_app_number] => 299567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3652907 [patent_doc_number] => 05658568 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Cytotoxic drug therapy' [patent_app_type] => 1 [patent_app_number] => 8/256475 [patent_app_country] => US [patent_app_date] => 1994-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 9790 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658568.pdf [firstpage_image] =>[orig_patent_app_number] => 256475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622806 [patent_doc_number] => 05641860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Cell surface protein JL-1 expressed on human cortical thymocyte and its use' [patent_app_type] => 1 [patent_app_number] => 8/247985 [patent_app_country] => US [patent_app_date] => 1994-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5760 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641860.pdf [firstpage_image] =>[orig_patent_app_number] => 247985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3701630 [patent_doc_number] => 05653980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Vaccine comprising part of constant region of IgE for treatment of IgE-mediated allergic reactions' [patent_app_type] => 1 [patent_app_number] => 8/196227 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7324 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/653/05653980.pdf [firstpage_image] =>[orig_patent_app_number] => 196227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729052 [patent_doc_number] => 05635356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Anti-oncoimmunin-M antibodies and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/218023 [patent_app_country] => US [patent_app_date] => 1994-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 40 [patent_no_of_words] => 21389 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635356.pdf [firstpage_image] =>[orig_patent_app_number] => 218023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656520 [patent_doc_number] => 05656272 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Methods of treating TNF-.alpha.-mediated Crohn\'s disease using chimeric anti-TNF antibodies' [patent_app_type] => 1 [patent_app_number] => 8/192102 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 48 [patent_no_of_words] => 48318 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656272.pdf [firstpage_image] =>[orig_patent_app_number] => 192102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622892 [patent_doc_number] => 05641865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment' [patent_app_type] => 1 [patent_app_number] => 8/188571 [patent_app_country] => US [patent_app_date] => 1994-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11315 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641865.pdf [firstpage_image] =>[orig_patent_app_number] => 188571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057590 [patent_doc_number] => 05866123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Gene encoding cationic amino acid transporter protein' [patent_app_type] => 1 [patent_app_number] => 8/187634 [patent_app_country] => US [patent_app_date] => 1994-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 10994 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866123.pdf [firstpage_image] =>[orig_patent_app_number] => 187634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734297 [patent_doc_number] => 05753225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Antibodies that mimic actions of neurotrophins' [patent_app_type] => 1 [patent_app_number] => 8/162597 [patent_app_country] => US [patent_app_date] => 1993-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16795 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753225.pdf [firstpage_image] =>[orig_patent_app_number] => 162597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847565 [patent_doc_number] => 05766886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Modified antibody variable domains' [patent_app_type] => 1 [patent_app_number] => 8/107669 [patent_app_country] => US [patent_app_date] => 1993-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 21761 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766886.pdf [firstpage_image] =>[orig_patent_app_number] => 107669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692379 [patent_doc_number] => 05679548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Methods for producing polypeptide metal binding sites and compositions thereof' [patent_app_type] => 1 [patent_app_number] => 8/077797 [patent_app_country] => US [patent_app_date] => 1993-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 28668 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679548.pdf [firstpage_image] =>[orig_patent_app_number] => 077797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857184 [patent_doc_number] => 05795572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Monoclonal antibodies and FV specific for CD2 antigen' [patent_app_type] => 1 [patent_app_number] => 8/068946 [patent_app_country] => US [patent_app_date] => 1993-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13514 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795572.pdf [firstpage_image] =>[orig_patent_app_number] => 068946 [rel_patent_id] =>[rel_patent_doc_number] =>)